Skip Navigation Change Font Size

Audit (A-02-11-02009)

08-27-2012
Bio Signal Group Corp., Did Not Always Claim Recovery Act Costs in Accordance With Federal Requirements

Executive Summary

In March 2010, the National Institutes of Health awarded Bio Signal Group Corp. (Bio Signal), a for-profit company in Brooklyn, New York, a 3-year grant totaling $2.9 million under the American Recovery and Reinvestment Act of 2009. Of that amount, we reviewed $725,000 in costs claimed by Bio Signal.

We determined that Bio Signal did not always claim costs in accordance with the terms of the Recovery Act grant and applicable Federal regulations. Bio Signal claimed $581,000 in allowable costs. However, the remaining costs totaling $144,000 were not allowable.

Complete Report

Download the complete report

Adobe® Acrobat® is required to read PDF files.

I'm Looking For

Let's start by choosing a topic

Exclusions Database Report Fraud
Newsletter Sign Up Envelop Graphic

Stay up to date on the latest OIG news and opinions

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201